HI-Bio
Biogen Expands Immunology Portfolio with $1.15 Billion Acquisition of HI-Bio
Biogen, HI-Bio, acquisition, immunology, $1.15 billion, expansion, therapeutics, drug development
Actionable Insights Powered by AI
Biogen, HI-Bio, acquisition, immunology, $1.15 billion, expansion, therapeutics, drug development